Patent: 10,040,783
✉ Email this page to a colleague
Summary for Patent: 10,040,783
Title: | Prostaglandin receptor EP2 antagonists, derivatives, compositions, and uses related thereto |
Abstract: | The disclosure relates to Prostaglandin receptor EP2 antagonists, derivatives, compositions, and methods related thereto. In certain embodiments, the disclosure relates to methods of treating or preventing conditions and diseases in which EP2 receptor activation has a physiological role, such as but not limited to, brain injury, inflammatory diseases, neuroinflammation after a seizure, pain, endometriosis, cancer, rheumatoid arthritis, skin inflammation, vascular inflammation, colitis, and neurological disorders by administering a pharmaceutical composition comprising a compound disclosed herein to a subject in need thereof. |
Inventor(s): | Jiang; Jianxiong (Decatur, GA), Ganesh; Thota (Alpharetta, GA), Du; Yuhong (Atlanta, GA), Thepchatri; Pahk (Atlanta, GA), Quan; Yi (Decatur, GA), Dingledine; Ray J. (Atlanta, GA) |
Assignee: | Emory University (Atlanta, GA) |
Application Number: | 15/365,850 |
Patent Claims: | see list of patent claims |
Details for Patent 10,040,783
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Organon Usa Inc., A Subsidiary Of Merck & Co., Inc. | COTAZYM | pancrelipase | Capsule, Delayed Release | 020580 | 12/09/1996 | ⤷ Try a Trial | 2031-06-20 |
Abbvie Inc. | CREON | pancrelipase | Capsule, Delayed Release | 020725 | 04/30/2009 | ⤷ Try a Trial | 2031-06-20 |
Abbvie Inc. | CREON | pancrelipase | Capsule, Delayed Release | 020725 | 06/10/2011 | ⤷ Try a Trial | 2031-06-20 |
Abbvie Inc. | CREON | pancrelipase | Capsule, Delayed Release | 020725 | 03/14/2013 | ⤷ Try a Trial | 2031-06-20 |
Digestive Care, Inc. | PERTZYE | pancrelipase | Capsule, Delayed Release | 022175 | 05/17/2012 | ⤷ Try a Trial | 2031-06-20 |
Digestive Care, Inc. | PERTZYE | pancrelipase | Capsule, Delayed Release | 022175 | 10/06/2016 | ⤷ Try a Trial | 2031-06-20 |
Digestive Care, Inc. | PERTZYE | pancrelipase | Capsule, Delayed Release | 022175 | 07/13/2017 | ⤷ Try a Trial | 2031-06-20 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |